C9orf142 transcriptionally activates MTBP to drive progression and resistance to CDK4/6 inhibitor in triple‐negative breast cancer
Li Liao(Shanghai Medical College of Fudan University), Da‐Qiang Li(Shanghai Medical College of Fudan University)
Cited by 5
Related Papers
Acetylation of MORC2 by NAT10 regulates cell-cycle checkpoint control and resistance to DNA-damaging chemotherapy and radiotherapy in breast cancer
|Nucleic Acids Research|2020|228
O-GlcNAcylation of MORC2 at threonine 556 by OGT couples TGF-β signaling to breast cancer progression
|Cell Death and Differentiation|2022|97
USP9X stabilizes BRCA1 and confers resistance to DNA‐damaging agents in human cancer cells
|Cancer Medicine|2019|49
Requirement of MTA1 in ATR-mediated DNA Damage Checkpoint Function
|Journal of Biological Chemistry|2010|41